DAFNA Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $860K | Hold |
|
|||||
|
2024
Q4 | $588K | Hold |
|
|||||
|
2024
Q3 | $781K | Sell |
|
|||||
|
2024
Q2 | $1.26M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $5.31M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $8.48M | Hold |
|
|||||
|
2023
Q1 | $7.57M | Hold |
|
|||||
|
2022
Q4 | $6.88M | Hold |
|
|||||
|
2022
Q3 | $7.06M | Hold |
|
|||||
|
2022
Q2 | $5.82M | Hold |
|
|||||
|
2022
Q1 | $5.97M | Hold |
|
|||||
|
2021
Q4 | $7.67M | Hold |
|
|||||
|
2021
Q3 | $7.99M | Buy |
|
|||||
|
2021
Q2 | $9.68M | Sell |
|
|||||
|
2021
Q1 | $13.6M | Hold |
|
|||||
|
2020
Q4 | $15.7M | Buy |
|
|||||
|
2020
Q3 | $9.68M | Sell |
|
|||||
|
2020
Q2 | $6.87M | Hold |
|
|||||
|
2020
Q1 | $4.75M | Buy |
|
|||||
|
2019
Q4 | $9.01M | Hold |
|
|||||
|
2019
Q3 | $17.5M | Buy |
|
|||||
|
2019
Q2 | $22.7M | Hold |
|
|||||
|
2019
Q1 | $19.7M | Buy |
|
|||||
|
2018
Q4 | $9.99M | Buy |
|
|||||
|
2018
Q3 | $14M | Buy |
|
|||||
|
2018
Q2 | $15M | Buy |
|
|||||
|
2018
Q1 | $15.1M | Buy |
|
|||||
|
2017
Q4 | $4.74M | Buy |
|